Docetaxel anhydrous

CAS: 114977-28-5 
EP/USP
USDMF No. 22562,USFDA  Approved, EU GMP
CEP: R0-CEP 2013-174 Rev 00
1
1
药丸3
药丸3
实验
实验
药丸2
药丸2
人像
人像

PRODUCTS

Back

Technical Data

 

M. Wt 807.9
Formula C43H53NO14
CAS Number 114977-28-5
PubChem ID 148124
InChI Key ZDZOTLJHXYCWBA-VCVYQWHSSA-N
Smiles [H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1
Documents EU GMP, CEP, USFDA Approved, USDMF, India Registered with Form41

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

 

Description

 

Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Docetaxel reversibly binds to tubulin with high affinity in a 1:1 stoichiometric ratio

 

Synonyms

 

Docetaxel, Docetaxel anhydrous, N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel, N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol, Taxotere, Docetaxol,  Anhydrous Docetaxel

 

Disclaimer

 

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)

 

Docetaxelanhydrous